The Senate will consider Mr. Azar’s nomination Jan. 9. If approved, Mr. Azar will join the Trump administration after 10 years at pharmaceutical company Eli Lilly, where he served the latter half of his tenure as president of the U.S. division. Mr. Azar also has a background in politics and policy, clerking for the late Justice Antonin Scalia and later serving two terms as general counsel of HHS under President George W. Bush.
“Mr. Azar’s years of experience in both the private and public sectors equips him well to effectively lead this complex agency,” said FAH President and CEO Chip Khan in a statement. “We encourage the U.S. Senate to confirm Mr. Azar quickly. We look forward to working with him on further improving American healthcare delivery and financing.”
More articles on leadership and management:
Idaho governor signs order to loosen ACA restrictions, offer lower-cost plans
New book claims Trump proposed Medicare-for-all in beginning of presidency
Trump to receive, allegedly publicize results of medical exam this week: 6 things to know
At Becker's 4th Annual CEO + CFO Roundtable, taking place November 2–5 in Chicago, more than 1,500 hospital and health system executives tackle decisions that determine whether organizations thrive or merely survive: protecting margins under cost pressure, choosing where to grow, renegotiating payer relationships, stabilizing the workforce and proving real ROI on technology. This is where leaders work through them together, face-to-face. Apply for complimentary registration now.